Raffaele Petrone

Life Sciences Capital Srl(Life Sciences Capital) is a venture capital subsidiary of Fin Posillipo SpA founded in 2005 by William A. Cavendish. The firm is headquartered in Napoli, Italy.

Part of RELIEF THERAPEUTICS Holding SA, Pierrel Research International AG provides drug development and clinical research services. The company is based in Essen, Germany. The CEO of the German company is Luigi Visani. Pierrel Research International was acquired by THERAMetrics holding AG from Pierrel SpA on January 25, 2013.

THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland.

Part of Fin Posillipo SpA, Petrone Group Srl is a pharmaceutical wholesaler and supplier. The company is based in Naples, Italy. The Italian company was founded in 1965 by Carmine Petrone, Fernanda Petrone. The CEO is Pierluigi Petrone.

Pharmaidea SRL operates as a pharmaceutical company. It engages in the marketing, sales, provision of scientific information, and product distribution. The company was founded in 2000 and is headquartered in Travagliato, Italy.

Fin Posillipo SpA provides financial and business consulting services. It helps small and medium-sized enterprises in the health and pharmaceutical sectors such as financial advice and fiscal and administrative consulting. The company was founded in 1989 and is headquartered in Naples, Italy.

STM Pharma PRO, Petrone Group provides pharmaceutical logistics and clinical trial services. The private company is based in Naples, Italy. The Italian company specializes in managing experimental drugs and clinical studies.

Part of ICU Medical, Inc., ICU Medical Italia Srl is a medical device company based in Rome, Italy. The Italian company is trusted by clinicians worldwide for their innovative, cost-effective medical devices that are safe, life-saving, and life-enhancing. The company's Tego Connector is designed to help protect patients' catheters from contamination and increased risk of catheter-related bloodstream infections (CRBSIs) during hemodialysis and apheresis applications.

Newcleo Ltd. is a British company that is disrupting the nuclear energy industry to play its part in climate change mitigation and decarbonization. Newcleo is based in an undisclosed location. The company is focused on reducing the environmental impact of nuclear fission and providing safe and clean energy to meet the growing energy needs. Newcleo has announced an agreement to purchase the outstanding shares of the Rütschi Group for a consideration of EUR 68.9 million. The company is planning ahead to work together with potential local, regional, and international suppliers to maximize the opportunities that Newcleo can bring. The company was founded in 2021 by Elisabeth Rizzotti and Stefano Buono, who has been the CEO since 2021.